266 related articles for article (PubMed ID: 38257800)
1. Investigating the Potential Shared Molecular Mechanisms between COVID-19 and Alzheimer's Disease via Transcriptomic Analysis.
Fan Y; Liu X; Guan F; Hang X; He X; Jin J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257800
[TBL] [Abstract][Full Text] [Related]
2. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment.
Zhou Y; Xu J; Hou Y; Leverenz JB; Kallianpur A; Mehra R; Liu Y; Yu H; Pieper AA; Jehi L; Cheng F
Alzheimers Res Ther; 2021 Jun; 13(1):110. PubMed ID: 34108016
[TBL] [Abstract][Full Text] [Related]
3. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.
Chen F; Chen Y; Wang Y; Ke Q; Cui L
Transl Neurodegener; 2022 Sep; 11(1):40. PubMed ID: 36089575
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
5. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
6. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
Zheng Q; Wang D; Lin R; Lv Q; Wang W
Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
[TBL] [Abstract][Full Text] [Related]
7. Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
Wang F; Xu J; Xu SJ; Guo JJ; Wang F; Wang QW
J Alzheimers Dis; 2022; 85(2):729-744. PubMed ID: 34776447
[TBL] [Abstract][Full Text] [Related]
8. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
9. Human-derived air-liquid interface cultures decipher Alzheimer's disease-SARS-CoV-2 crosstalk in the olfactory mucosa.
Shahbaz MA; Kuivanen S; Lampinen R; Mussalo L; Hron T; Závodná T; Ojha R; Krejčík Z; Saveleva L; Tahir NA; Kalapudas J; Koivisto AM; Penttilä E; Löppönen H; Singh P; Topinka J; Vapalahti O; Chew S; Balistreri G; Kanninen KM
J Neuroinflammation; 2023 Dec; 20(1):299. PubMed ID: 38098019
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes.
Liu X; Chen Y; Tang W; Zhang L; Chen W; Yan Z; Yuan P; Yang M; Kong S; Yan L; Qiao J
Sci China Life Sci; 2020 Jul; 63(7):1006-1015. PubMed ID: 32361911
[TBL] [Abstract][Full Text] [Related]
11. Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?
Rudnicka-Drożak E; Drożak P; Mizerski G; Zaborowski T; Ślusarska B; Nowicki G; Drożak M
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767513
[TBL] [Abstract][Full Text] [Related]
12. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.
Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
Front Immunol; 2022; 13():918692. PubMed ID: 36059456
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W
Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193
[TBL] [Abstract][Full Text] [Related]
18. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
20. The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection.
Nuovo GJ; Suster D; Sawant D; Mishra A; Michaille JJ; Tili E
Ann Diagn Pathol; 2022 Dec; 61():152057. PubMed ID: 36334414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
